Download
s11239-021-02617-x.pdf 853,63KB
WeightNameValue
1000 Titel
  • Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease
1000 Autor/in
  1. Gauchel, Nadine |
  2. Rieder, Marina |
  3. Krauel, Krystin |
  4. Goller, Isabella |
  5. Jeserich, Maren |
  6. Salzer, Ulrich |
  7. Venhoff, Ana Cecilia |
  8. Baldus, Niklas |
  9. Pollmeier, Luisa |
  10. Wirth, Luisa |
  11. Kern, Winfried |
  12. Rieg, Siegbert |
  13. Busch, Hans-Jörg |
  14. Hofmann, Maike |
  15. Bode, Christoph |
  16. Duerschmied, Daniel |
  17. Lother, Achim |
  18. Heger, Lukas |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-12-14
1000 Erschienen in
1000 Quellenangabe
  • 53(4):788-797
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11239-021-02617-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668393/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The complement system (CS) plays a pivotal role in Coronavirus disease 2019 (COVID-19) pathophysiology. The objective of this study was to provide a comparative, prospective data analysis of CS components in an all-comers cohort and COVID-19 patients. Patients with suspected COVID-19 infection admitted to the Emergency department were grouped for definite diagnosis of COVID-19 and no COVID-19 accordingly. Clinical presentation, routine laboratory and von Willebrand factor (vWF) antigen as well as CS components 3, 4 and activated 5 (C5a) were assessed. Also, total complement activity via the classical pathway (CH50) was determined. Levels of calprotectin in serum were measured using an automated quantitative lateral flow assay. We included 80 patients in this prospective trial. Of those 19 (23.7%) were tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19 had higher levels of CS components 5a and 4 (54.79 [24.14-88.79] ng/ml vs. 35 [23.15-46.1] ng/ml; p = 0.0433 and 0.3772 [± 0.1056] g/L vs. 0.286 [0.2375-0.3748] g/L; p = 0.0168). COVID-19 patients had significantly higher levels of vWF antigen when compared to the control group (288.3 [± 80.26] % vs. 212 [151-320] %; p = 0.0469). There was a significant correlation between CS C3 and 5a with vWF antigen (r
1000 Sacherschließung
lokal COVID-19/diagnosis [MeSH]
gnd 1206347392 COVID-19
lokal Complement components
lokal von Willebrand Factor/analysis [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal COVID-19
lokal Von Willebrand factor
lokal Coagulopathy
lokal Article
lokal Emergency Service, Hospital [MeSH]
lokal Calprotectin
lokal Leukocyte L1 Antigen Complex [MeSH]
lokal SARS-CoV-2 [MeSH]
lokal Immunologic Factors [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/R2F1Y2hlbCwgTmFkaW5l|https://frl.publisso.de/adhoc/uri/UmllZGVyLCBNYXJpbmE=|https://frl.publisso.de/adhoc/uri/S3JhdWVsLCBLcnlzdGlu|https://frl.publisso.de/adhoc/uri/R29sbGVyLCBJc2FiZWxsYQ==|https://frl.publisso.de/adhoc/uri/SmVzZXJpY2gsIE1hcmVu|https://frl.publisso.de/adhoc/uri/U2FsemVyLCBVbHJpY2g=|https://frl.publisso.de/adhoc/uri/VmVuaG9mZiwgQW5hIENlY2lsaWE=|https://frl.publisso.de/adhoc/uri/QmFsZHVzLCBOaWtsYXM=|https://frl.publisso.de/adhoc/uri/UG9sbG1laWVyLCBMdWlzYQ==|https://frl.publisso.de/adhoc/uri/V2lydGgsIEx1aXNh|https://frl.publisso.de/adhoc/uri/S2VybiwgV2luZnJpZWQ=|https://frl.publisso.de/adhoc/uri/UmllZywgU2llZ2JlcnQ=|https://frl.publisso.de/adhoc/uri/QnVzY2gsIEhhbnMtSsO2cmc=|https://frl.publisso.de/adhoc/uri/SG9mbWFubiwgTWFpa2U=|https://frl.publisso.de/adhoc/uri/Qm9kZSwgQ2hyaXN0b3Bo|https://frl.publisso.de/adhoc/uri/RHVlcnNjaG1pZWQsIERhbmllbA==|https://frl.publisso.de/adhoc/uri/TG90aGVyLCBBY2hpbQ==|https://orcid.org/0000-0002-9419-5675
1000 Hinweis
  • DeepGreen-ID: 87e6f5ef7581458ea6b10dc656e898c7 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6445930.rdf
1000 Erstellt am 2023-04-28T11:41:56.565+0200
1000 Erstellt von 322
1000 beschreibt frl:6445930
1000 Zuletzt bearbeitet Fri Oct 20 17:12:21 CEST 2023
1000 Objekt bearb. Fri Oct 20 17:12:21 CEST 2023
1000 Vgl. frl:6445930
1000 Oai Id
  1. oai:frl.publisso.de:frl:6445930 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source